Targeting the SARS-CoV-2 3CL pro and NO/cGMP/PDE5 Pathway in COVID-19: A Commentary On PDE5 Inhibitors
Author(s) -
Milad Shirvaliloo
Publication year - 2021
Publication title -
future cardiology
Language(s) - English
Resource type - Journals
eISSN - 1744-8298
pISSN - 1479-6678
DOI - 10.2217/fca-2020-0201
Subject(s) - medicine , sildenafil , tadalafil , vardenafil , covid-19 , hydroxychloroquine , repurposing , erectile dysfunction , severe acute respiratory syndrome , disease , intensive care medicine , infectious disease (medical specialty) , ecology , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom